Cheryl-Peterson-2_heart-walk-2020.jpg[54]

2020 Bert Blain Memorial Virtual Heart Walk chair and SHINE community and employee engagement manager, Cheryl Peterson, walking with family to promote heart health.

JANESVILLE, Wis., September 20, 2020 – SHINE Medical Technologies LLC today announced that its team for the Bert Blain Memorial Virtual Heart Walk raised more than $13,000 to support the American Heart Association’s mission of reducing disability and death caused by heart disease and stroke.

This is the fourth year that SHINE has participated in the Heart Walk, which was held virtually this year due to the coronavirus pandemic. Walkers were invited to walk in the safety of their own neighborhoods. The SHINE team has nearly doubled the funds it has raised each walk since 2017, when it began participating. The team has a four-year fundraising total of more than $28,000.

“SHINE employees, family members and friends are extremely proud to raise money for heart disease and stroke research through the Annual Bert Blain Memorial Heart Walk,” said Cheryl Peterson, the 2020 heart walk chair and community and employee engagement manager at SHINE. “Now more than ever, it is important to keep our hearts healthy, as a healthy heart helps fight off the coronavirus. About one in three people with the virus has cardiovascular disease, making it the most common underlying health condition.”

SHINE encourages employee participation in community events that complement its mission, including those that support the eradication of heart disease and cancer.

About SHINE Medical Technologies LLC
SHINE is a nuclear technology company committed to improving the lives of patients around the world. The company is focused initially on the commercialization of medical isotopes, including molybdenum-99, a diagnostic isotope used to diagnose heart disease, cancer and other diseases, and lutetium-177, a therapeutic isotope that holds the promise of significantly improving the outcomes for some cancer patients. SHINE has created isotope production processes that will deliver products to benefit physicians and patients and help solve critical supply problems in the United States and markets in Europe and around the world. SHINE has a long-term strategy to solve some of humanity’s biggest problems and advance our vision for progressively broad and impactful uses of nuclear technology. For more information, please visit our website at www.shinetechnologies.com.

Contact:

MALLORY PROUTY
CORPORATE COMMUNICATIONS PROJECT MANAGER, MBA

mallory.prouty@shinemed.com
P: 608-530-5606 | M: 630-945-2379

ROD HISE
DIRECTOR, MARKETING & CORPORATE COMMUNICATIONS

rod.hise@shinemed.com
P 608-530-5659 | M 608-770-7850